In cisplatin-resistant small cell lung cancer (SCLC), napabucasin induces apoptosis by cleavage PARP and suppression of antiapoptotic proteins Mcl-1 and survivin [13]. This evidence concerns the gene BIRC5 and small cell lung carcinoma.